Laferon-FarmBiotek lyophilisate for solution for injections 3 mln IU №10 vial


Manufacturer: Germany



Laferon-of PharmBiotek is used in the treatment of: acute and chronic viral hepatitis B (moderate and severe forms); chronic hepatitis C; acute viral, bacterial and mixed infections (including acute respiratory viral infection in children, including newborns, acute diarrhoeal syndrome in newborns, acute intestinal infections in young children with hypocoagulation phenomena); acute and chronic septic diseases of viral and bacterial nature, including disseminated forms of acute and chronic sepsis; herpetic infections of various localization: shingles, multiple skin herpetic rashes; genital herpetic infection; herpetic keratoconjunctivitis and keratouveitis, acute herpetic stomatitis in children; chronic urogenital chlamydia; lesions of the nervous system with mono-and polyradicular pain syndromes; multiple sclerosis; laryngeal papillomatosis; melanoma of the skin and eye; cancer of the kidney, bladder, ovary, breast; Kaposi’s sarcoma, myeloma; chronic myeloid leukemia, hairy cell leukemia, non-Hodgkin’s malignant lymphomas, basal cell carcinoma; T-cell skin lymphoma (fungal mycosis).